COVID-19 has widened the vast screening gap in colorectal cancer (CRC).1 Don’t wait—screen your patients today.
SCREEN EVERY ELIGIBLE PATIENT AT AVERAGE RISK FOR CRC
ONE YES AT A TIME
Offering patients a choice in CRC screening matters. Cologuard is an effective, noninvasive CRC screening option for patients aged 45 years and older at average risk.2
